44 Results
Position Statement on the Use of Antipsychotic Medication in Patients with Major Neurocognitive Disorder
Position Statement on the Use of Antipsychotic Medication in Patients with Major Neurocognitive Disorder
Position Statement on Screening and Treatment of Mood and Anxiety Disorders During Pregnancy and Postpartum
Position Statement on Screening and Treatment of Mood and Anxiety Disorders During Pregnancy and Postpartum
Position Statement on Screening and Treatment of Mood and Anxiety Disorders During Pregnancy and Postpartum
Position Statement on Screening and Treatment of Mood and Anxiety Disorders During Pregnancy and Postpartum
Position Statement on Recognition and Management of Addictive Disorders and Other Mental Illnesses Multimorbid with HIV
Position Statement on Recognition and Management of Addictive Disorders and Other Mental Illnesses Multimorbid with HIV
Position Statement on the Impact of Structural Racism on Substance Use and Substance Use Disorders
Position Statement on the Impact of Structural Racism on Substance Use and Substance Use Disorders
Position Statement on Integrating Opioid Use Disorders Treatment with Buprenorphine and Naltrexone with that of Co-Occurring Mental Illnesses
Position Statement on Integrating Opioid Use Disorders Treatment with Buprenorphine and Naltrexone with that of Co-Occurring Mental Illnesses
Position Statement on Inquiries about Diagnosis and Treatment of Mental Disorders in Connection with Professional Credentialing and Licensing
Position Statement on Inquiries about Diagnosis and Treatment of Mental Disorders in Connection with Professional Credentialing and Licensing
Gender identity disorder, Report of the APA Task Force on treatment of
After the announcement of the DSM-5 Work Group membership in May 2008, the American Psychiatric Association (APA) received many inquiries regarding the workgroup named to address the entities included under Gender Identity Disorder (GID) in versions III through IVTR of the Diagnostic and Statistical Manual of Mental Disorders™ (DSM). These inquiries most often dealt with treatment controversies regarding GID, especially in children, rather than issues related specifically to the DSM text and dia
Harm Reduction
Harm reduction is an evidence-based, standard-of-care approach that aims to reduce the harm that patients experience while using substances. It recognizes that the use of substances is an inherent component of substance use disorder and that some ways of using illicit substances are less harmful to patient medical, social, and psychological health than others.
Neuroimaging
The application of neuroimaging technology in psychiatric research has revolutionized clinical neuroscience perspectives on the pathophysiology of the major psychiatric disorders. Research using a variety of types of neuroimaging techniques has shown that these conditions are associated with abnormalities of brain function, structure and receptor pharmacology. These data also corroborate the conclusions reached from genetic, endocrine, and clinical pharmacology research involving these disorders
Access to Firearms by People with Mental Disorders
Gun violence is a major public health problem in our country. Recent data indicate that 19,392 people used a gun to kill themselves in 2010, and 11,078 killed someone else with a firearm (1). In 2003, the homicide rate in the United States was seven times higher than the average of other high-income countries (2). Although concern is understandably heightened when mass tragedies occur, the daily occurrence of scores of murders and suicides due to the use of guns rarely gets the attention afforde
Neuroimaging markers of psychiatric disorders, Consensus report of the APA Work Group on
In May 2009, an Action paper was passed by the APA Assembly calling for the development of an APA Position Paper on the Clinical Application of Brain Imaging in Psychiatry. This action paper was developed in response to questions raised by claims being made that brain imaging technology had already reached the point that it was useful for making a clinical diagnosis and for helping in treatment selection.